Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation
about
Homeodomain-interacting protein kinase 2 plays an important role in normal terminal erythroid differentiationInvolvement of the Hipk family in regulation of eyeball size, lens formation and retinal morphogenesisWnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLKRole of HIPK2 in kidney fibrosisOverlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.Essential function of HIPK2 in TGFbeta-dependent survival of midbrain dopamine neuronsInteraction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survivalTranscriptional corepressors HIPK1 and HIPK2 control angiogenesis via TGF-β-TAK1-dependent mechanismAxin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formationTRPV4, TRPC1, and TRPP2 assemble to form a flow-sensitive heteromeric channelHIPK2: a multitalented partner for transcription factors in DNA damage response and development.The Kto-Skd complex can regulate ptc expression by interacting with Cubitus interruptus (Ci) in the Hedgehog signaling pathway.Homeodomain-interacting protein kinase (HIPK)-1 is required for splenic B cell homeostasis and optimal T-independent type 2 humoral response.Expression profiling of transforming growth factor beta superfamily genes in developing orofacial tissue.Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling.Cell death and the developing enteric nervous system.Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradationPleiotropic effects of the bone morphogenetic proteins on development of the enteric nervous system.Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.Ski and SnoN, potent negative regulators of TGF-beta signaling.c-Ski in health and disease.SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis.Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly.miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage.Axin determines cell fate by controlling the p53 activation threshold after DNA damage.p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytesTranscription factors-Intricate players of the bone morphogenetic protein signaling pathway.HIV-1 Tat impairs cell cycle control by targeting the Tip60, Plk1 and cyclin B1 ternary complex.
P2860
Q24303477-F1B3A629-4238-43A3-91DB-4893DBF816BAQ24336386-B7DA8D46-64C0-49A6-AA3A-770F8AA47AF6Q24624946-856DF061-93E1-47FB-8892-6C6F283A62F7Q26796620-5D68A543-6F6A-4DDA-9494-D6DA1BFE0702Q28505801-E09CE278-1AE6-45FC-998D-2AA5861182F8Q28507585-7228DABA-0F64-4237-B9BB-4E2BA23B27BDQ28509866-248606F2-49A1-42FD-8C8F-F2673FCC1106Q28585338-E1C54FD2-D421-487E-85B1-3D980BA36E17Q28587574-A78DE8DA-4C41-4B7F-AA56-33909F45578DQ30593487-8491B6B5-D584-49DE-8ECF-4BB4052BF64AQ31122379-80301EDC-8415-4AFC-9C46-4AB2FE6600FCQ34070454-AF556788-7EE6-4456-9957-88C7EEA21919Q34251143-B5D7A95B-0B36-468A-B1A1-13B733606274Q34284505-F3C352E0-4FD0-448B-AEC8-4D23447AF744Q36092218-D47E8159-CB98-4F2C-A22A-D12CBC414928Q36098814-31AB722A-BBE4-4C1E-85DF-F3D1AACFD98EQ36216463-5C3D1030-17D7-40EF-B633-E874DA0FAC8FQ36295022-9CBD5749-13CE-4B4C-BEDE-02C589CA2D37Q36408011-4316A49A-A619-4864-AF0F-09EA7E9008F9Q37359949-534B2BBD-11EE-4496-AE7D-59FDD9E0F0EDQ37885788-A91AE4B4-77CC-4CBE-BD30-5B88230FD45DQ38266174-2316E3D3-FA35-47C3-A8DC-550AB48329A2Q38685123-CCD84EF4-E698-444B-973A-4A0F455BC05DQ38938083-8CEF8EC9-13C8-4F33-BBD7-1BC3E8BAF79EQ39160093-1915B885-3CAD-4519-94C5-93F54A8DB717Q39803554-BA032A28-EBF2-4CAB-8E5A-57FF23ACDB0CQ39850223-9A58FA2E-02F9-446F-BDEA-A67994093532Q41816907-8B88D1BD-2C6C-4E11-8BB0-04A7B21D56FEQ47878462-A8E30F35-8D9D-48D4-B56B-F6B524F80349Q53172505-744827A4-B002-4ACA-9EC2-E253FE256720
P2860
Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Requirement of the co-represso ...... ced transcriptional activation
@ast
Requirement of the co-represso ...... ced transcriptional activation
@en
Requirement of the co-represso ...... ced transcriptional activation
@en-gb
Requirement of the co-represso ...... ced transcriptional activation
@nl
type
label
Requirement of the co-represso ...... ced transcriptional activation
@ast
Requirement of the co-represso ...... ced transcriptional activation
@en
Requirement of the co-represso ...... ced transcriptional activation
@en-gb
Requirement of the co-represso ...... ced transcriptional activation
@nl
prefLabel
Requirement of the co-represso ...... ced transcriptional activation
@ast
Requirement of the co-represso ...... ced transcriptional activation
@en
Requirement of the co-represso ...... ced transcriptional activation
@en-gb
Requirement of the co-represso ...... ced transcriptional activation
@nl
P2093
P921
P356
P1476
Requirement of the co-represso ...... ced transcriptional activation
@en
P2093
Chie Kanei-Ishii
Jun Harada
Kenji Kokura
Md Matiullah Khan
Shunsuke Ishii
Teruaki Nomura
Yongsok Kim
P304
38998-9005
P356
10.1074/JBC.M307112200
P407
P577
2003-10-03T00:00:00Z